Insights | Case-Studies | Lambda Therapeutic Research

Home
/
Lambda Insights
/
Case-Studies

Case Study

Case-Study

Multicentre Paediatric Acceptability Study for Cyclophosphamide Powder

Case-Study

From Study Execution to EMA Success A Global Phase III Program for Ranibizumab – Ophthalmic Biosimilar

Case-Study

Insights: Bioequivalence Study of Semaglutide Injection

Case-Study

Audit and Inspection Readiness: A Comprehensive Approach

Case-Study

Accelerating Patient Recruitment in Ranibizumab Study for Retinopathy of Prematurity in Preterm Infants

Case-Study

Overcoming challenges in a Patient-based PK study (Paliperidone) held during the COVID-19 pandemic

Case-Study

Insights – Administering Iron Sucrose IV Injection through Infusion Pump to over 150 Healthy Participants

Case-Study

Meeting MI PV Obligations for a COVID-19 Vaccine Partnering for Multi-Country Compliance

Case-Study

Advancing Breast Cancer Research – Lambda and Novum’s Commitment to Patient-Centric Trials

Case-Study

Advancing Pediatric Clinical Trials – Overcoming Challenges in the Clinical Trial of Pegfilgrastim

Case-Study

Accelerating Patient Recruitment: Atopic Dermatitis Trials | Topical Tacrolimus

Case-Study

Overcoming Challenges in a Multicenter Oncology Clinical Trial

Case-Study

Overcoming Challenges in a Bioequivalence Assessment Study of Octreotide Acetate Injection

Case-Study

From Logistics to Seamless Analysis: Enhancing Medical Imaging Efficiency with DiSoft

Let's Unveil New Therapies Together

Connect with our experts to leverage our proven track record of clinical research excellence.